Trial intelligence / Profile preview

Terlipressin for sepsis-associated hypotension in hospitalized adults

ACTRN12613001191785Phase 4Terminated

Sponsor
Anaesthesia Intensive Care Trust Fund
Start
Aug 2014
Modality
Peptides
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in sepsis and hypotension comparing Terlipressin with Placebo (2 arms). Primary endpoint: Mean arterial blood pressure. Started Aug 2014; status: terminated.

02

Drugs

terlipressin
03

Conditions

sepsishypotension

Beyond the preview

Go deeper on ACTRN12613001191785.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12613001191785.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call